Abstract

In the modern world, stressful situations and stress-related disorders have become widespread among the population, representing one of the most pressing medical and social problems. Experts from around the world have traced a clear connection between stress and the development of many diseases, both from the somatic, mental and behavioral levels. Regardless of gender and age, social and cultural status, any person is susceptible to stress, and physical, emotional, informational and/or any other impact can act as a provoking factor [7,8]. When diagnosing disorders caused by stressful events, medical specialists rely on patient complaints arising at the somatic level, without taking into account the mental component, while timely treatment of ordinary stressful conditions that reduce the response adaptive functions of the body, using sedatives, will help to avoid overstrain of the body and prevent the stage of exhaustion [1,7]. The purpose of the study is to analyze the pharmaceutical market for sedative drugs registered in the Russian Federation Federation. During the research, official sources of information on the nomenclature of sedatives were used: the State Register of Medicines, the Register of Medicines and the Vidal Medicines Directory with up-to-date information for 2023. The main analysis methods used in this article are: methods of grouping, retrospective, logical, graphic and structural analysis, content analysis. As a result of the study, the main trends in the development of the range of sedative drugs were determined, and a macro-contour of the pharmaceutical market of the group under study was compiled according to the main leading characteristics of drugs.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call